• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1235300-18
Device Problem Difficult To Position (1467)
Patient Problem Perforation (2001)
Event Date 02/21/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effect of perforation, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined; however, the difficult to position (cross-ability) appears to be related to the circumstances of the procedure and there is no indication of a product quality issue with respect to design, manufacture or labeling of the device.The graftmaster stent and xience alpine stent are filed under separate manufacturer report numbers.
 
Event Description
It was reported that the patient underwent a procedure to treat a target lesion in the diagonal artery.Pre-dilatation was performed at the target lesion and the 3.0 x 18 mm absorb bioresorbable vascular scaffold (bvs) was implanted without difficulty.Post dilatation was performed and a perforation was noted distal to the scaffolded area.A 2.8 x 16 mm graftmaster stent was advanced to the perforation site, using a non-abbott guide catheter extension for support.Due to the patient anatomy, the use of the guide catheter extension and advancement distally through the implanted absorb, resistance was met and positioning was difficult; therefore, the 2.8 x 16 mm graftmaster did not fully cover the perforation but sealed the area where it was implanted.A second 2.8 x 19 mm graftmaster stent delivery system was advanced and was able to cover the remaining perforation.During use of the non-abbott guide catheter extension, as the guide catheter extension was engaged in the left anterior descending artery, a dissection occurred (caused by the guide catheter extension).A 3.0 x 15 mm xience alpine was advanced to the dissection and deployed.Post-dilatation was performed using a 4.0 x 15 mm nc trek.After the nc trek was removed, the dissection flap was noted to cover the diagonal artery, occluding flow into the diagonal artery.No additional intervention was performed to treat the occlusion.During the procedure, the patient remained pain-free.Post-procedure, a small amount of blood was noted in the pericardium; however, this was not treated.The patient was discharged from the cath lab in stable condition.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6386402
MDR Text Key69327728
Report Number2024168-2017-01903
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648213045
UDI-Public(01)08717648213045(17)170901(10)6090261
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 03/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2017
Device Catalogue Number1235300-18
Device Lot Number6090261
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DIL CATH: 3.0X15MM NC TREK
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-